Latest Content

A Stranger Who Became a Friend

November 19th 2025, 6:00pm

By Bonnie Annis

Article

I never dreamed a stranger could teach me so much about cancer, life and living with gratitude but I'm so glad she did!

How Targeted Therapies Are Transforming Chronic Myeloid Leukemia Care

November 19th 2025, 5:00pm

By Ryan Scott

Article

Dr. Jorge E. Cortes discussed the evolution of chronic myeloid leukemia treatment and emerging strategies aimed at improving outcomes and quality of life.

FDA Grants Fast Track Status to New Gastric Cancer Treatment

November 19th 2025, 4:00pm

By Spencer Feldman

Article

The oral therapy DPTX3186 received fast track status to help speed development of a potential new option for patients with gastric cancer.

Understanding the Diagnosis and Treatment of Neuroendocrine Tumors

November 19th 2025, 2:00pm

By Ryan Scott

Article

Dr. Pamela L. Kunz sat down with CURE to discuss Neuroendocrine Tumors, or NETs, Awareness Month.

Inside the ‘Weird and Wacky’ Frontier of New Targeted Therapy for Lung Cancer

November 18th 2025, 10:00pm

By Alex Biese

Article

Dr. Benjamin Herzberg spotlighted some of the “weird and wacky” new ideas in the field of targeted therapies for the treatment of lung cancer.

Understanding Emerging Cell Therapy in Lung Cancer

November 18th 2025, 9:22pm

By Ryan Scott

Article

Dr. Adam J. Schoenfeld delivered an extensive overview of how cellular therapies are shaping the future of lung cancer care.

Targeted Therapies Are Transforming Lung Cancer Treatment

November 18th 2025, 8:00pm

By Ryan Scott

Article

Dr. Catherine A. Shu highlights targeted therapies for patients with lung cancer, emphasizing advances, challenges and the importance of clinical trials.

Why I’m Excited HRT Is Finally Getting Attention

November 18th 2025, 6:00pm

By Georgia Hurst

Article

Many fail to recognize that estrogen is necessary to help your body and its parts work in concert with each other seamlessly.  

FDA Fast Tracks ITM-94 For Clear Cell Renal Cell Carcinoma Diagnosis

November 18th 2025, 5:00pm

By Alex Biese

Article

The FDA has granted fast track designation to ITM-94 as a diagnostic agent for the detection of the most common type of kidney cancer.

FDA Approves Epkinly Combo in Relapsed/Refractory Follicular Lymphoma

November 18th 2025, 4:00pm

By Alex Biese

Article

The FDA has approved Epkinly plus Revlimid and Rituxan for the treatment of patients with relapsed or refractory follicular lymphoma.

AI Tools Help Patients Navigate Complex Cancer Information

November 18th 2025, 2:00pm

By Ryan Scott

Article

Steve Brown and Lisa Booth explain how AI platforms like CureWise offer clarity, reduce anxiety, and support informed decisions during the cancer journey.